US Archives - Page 69 of 112 - European Medical Journal

Immunotherapy Combination Shows Promise for Early-Stage ERBB2-Positive Breast Cancer

A recent Phase I clinical trial has provided promising results for a novel immunotherapy approach to treat early-stage ERBB2-positive breast cancer.

Pediatric Flu Vaccine: 50% Effectiveness Proven

The consistent effectiveness of influenza vaccines in protecting children from severe flu-related illnesses has been highlighted in recently published findings.

Understanding Cognitive Challenges After Chemotherapy

A recently published systematic review has shed light on chemotherapy-related cognitive impairment (CRCI) and its association with changes in brain connectivity and function.

TNF Inhibitors Lower Fracture Risk in Axial Spondylarthritis

TNF inhibitors reduce fracture risk in axial spondyloarthritis, offering protection against complications from chronic inflammation.

Innovative Psoriasis Trial Boosts Diversity in Clinical Research

The VISIBLE trial sets a benchmark for diversity in psoriasis research, achieving rapid enrollment and valuable data for patients with skin of color.

Socioeconomic Disparities Impact Follow-Up for Pulmonary Nodules

Patients from disadvantaged neighborhoods are less likely to follow guidelines for pulmonary nodule care, highlighting socioeconomic disparities in healthcare access.

Multidrug-Resistant Shigella sonnei Detected in People Experiencing Homelessness

A recent study has revealed an alarming rise in multidrug-resistant Shigella sonnei in Vancouver, Canada among people experiencing homelessness.

A Breakthrough for Spinal Cord Injuries with Neural Stem Cell Transplants

Long-term trial finds neural stem cell transplants safe and shows neurological gains in spinal cord injury patients.

Study Highlights Cancer Risks and Outcomes for Rheumatoid Arthritis Patients

A new study from Western Australia reveals that while patients with rheumatoid arthritis (RA) have a lower overall cancer incidence compared to the general population, they face higher risks for lung and hematological cancers.

Current Trends in Pediatric Cosmetic Treatments

The most commonly treated pediatric cosmetic conditions included hypertrophic and traumatic scars, acne, axillary and facial hyperhidrosis.